Viewing Study NCT06140732


Ignite Creation Date: 2025-12-24 @ 9:29 PM
Ignite Modification Date: 2026-01-02 @ 9:39 AM
Study NCT ID: NCT06140732
Status: RECRUITING
Last Update Posted: 2023-11-20
First Post: 2023-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Sponsor: Xuanwu Hospital, Beijing
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chordoma View
None Chemotherapy Effect View
Keywords: